期刊文献+

伏立康唑对慢性阻塞性肺疾病合并肺部真菌感染患者肺顺应性及肺功能参数的影响观察 被引量:3

Observation on the influence of voriconazole for pulmonary compliance and pulmonary function parameters of patients with chronic obstructive pulmonary disease complicated with pulmonary fungal infection
下载PDF
导出
摘要 目的:观察与探究伏立康唑对慢性阻塞性肺疾病(慢阻肺)合并肺部真菌感染患者肺顺应性及肺功能参数的影响。方法:选取82例慢阻肺合并肺部真菌感染患者为研究对象,将所有患者根据随机数字表法分为对照组41例和观察组41例。对照组采用氟康唑进行治疗,观察组采用伏立康唑进行治疗。统计与比较两组的临床总有效率、不良反应发生率、治疗前后不同时间的症状体征评分、肺顺应性及肺功能参数。结果:观察组的临床总有效率高于对照组,差异有统计学意义(P<0.05),治疗前两组患者的症状体征评分、肺顺应性及肺功能参数比较,差异无统计学意义(P>0.05),治疗后不同时间观察组的症状体征评分均低于对照组,肺顺应性及肺功能参数均好于对照组,差异有统计学意义(P<0.05),两组的不良反应发生率比较,差异无统计学意义(P>0.05)。结论:伏立康唑对慢阻肺合并肺部真菌感染患者肺顺应性及肺功能参数的影响较好,在本类患者中的应用价值较高。 Objective To observe and investigate the influence of voriconazole for pulmonary compliance and pulmonary function parameters of patients with chronic obstructive pulmonary disease complicated with pulmonary fungal infection.Method 82 patients with chronic obstructive pulmonary disease complicated with pulmonary fungal infection in our hospital from January 2016 to July 2017 were selected as the study object,and all the patients were divided into control group 41 cases and observation group 41 cases by the random number table.The control group were treated with fluconazol,the observation group were treated with voriconazole.Then the total effective rates,adverse reaction rates,symptom and sign scores,pulmonary compliance and pulmonary function parameters at different time before and after the treatment of two groups were analyzed and compared.Results The total effective rate of observation was higher than the rate of control group,the difference was statistically significant(P<0.05),the symptom and sign scores,pulmonary compliance and pulmonary function parameters of observation group before the treatment were compare,the difference was not statistically significant(P>0.05),the symptom and sign scores of observation group of observation group at different time after the treatment were all lower than those of control group,the pulmonary compliance and pulmonary function parameters were all better than those of control group,the differences were statistically significant(P<0.05),the adverse reaction rates of two groups had no obviously differences(P>0.05).Conclusion The influence of voriconazole for pulmonary compliance and pulmonary function parameters of patients with chronic obstructive pulmonary disease complicated with pulmonary fungal infection are better,and the application value in these patients are higher.
作者 冯银合 曾春芳 FENG Yin-he;ZENG Chun-fang(Department of respiratory medicine,The People′s Hospital of Deyang,Sichuan,Deyang 618000,China)
出处 《吉林医学》 CAS 2019年第12期2727-2729,共3页 Jilin Medical Journal
关键词 伏立康唑 慢阻肺 肺部真菌感染 肺顺应性 肺功能参数 Voriconazole Chronic obstructive pulmonary disease Pulmonary fungal infection Pulmonary compliance Pulmonary function parameters
  • 相关文献

参考文献18

二级参考文献156

  • 1陈建,王广发.慢性阻塞性肺疾病全球倡议2011修订版解读[J].中国医学前沿杂志(电子版),2012,4(1):42-44. 被引量:65
  • 2侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:869
  • 3中华人民共和国卫生部.抗菌药物临床应用指导原则[M].北京:人民卫生出版社,2007:150. 被引量:25
  • 4张之南,沈悌.血液病的诊断与疗效标准[M].3版.北京:科学出版社,2007. 被引量:2
  • 5无.肺真菌病诊断和治疗专家共识[J].中华结核和呼吸杂志,2007,30(11):821-834. 被引量:616
  • 6Estey EH. Acute myeloid leukemia: 2012 update on diagno- sis, risk stratification, and management[J]. Am J Hemato- logic, 2012,87 : 89-99. 被引量:1
  • 7Gareia-Manero G. Myelodysplastie syndromesz 2012 update on diagnosis,risk stratification, and management[J]. Am J Hematologic, 2012,87 : 692-701. 被引量:1
  • 8G Maschmeyer WJ, Heinz B, Hertenstein, et al. Immediate versus deferred empirical antifungal (IDEA) therapy in high- risk patients with febrile neutropenia: a randomized, double- blind, placebo-controlled, multicenter study[J]. Eur J Clin Microbiol Infect Dis, 2013,3(2) : 679-689. 被引量:1
  • 9Bulpa P,Dive A,Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease[J].Eur Respir,2007,(4):782-800. 被引量:1
  • 10Nasa P, Yadav R, Nagrani SK, et al. Invasive pulmonary aspergillo- sis in an immunocompetent patient with severe dengue fever[J]. IndianJ Crit Care Med, 2014, 18(5): 323-325. 被引量:1

共引文献101

同被引文献34

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部